Literature DB >> 10644798

Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.

I Reuter1, M T Hu, T C Andrews, D J Brooks, C Clough, K R Chaudhuri.   

Abstract

Huntington's disease is characterised by hyperkinetic movements, mainly chorea, cognitive dysfunction, and psychiatric abnormalities. Non-dopa responsive parkinsonism occurs in the later stages of choreic disease or as the predominant feature of juvenile patients (Westphal variant). Late onset Huntington's disease presenting as levodopa responsive parkinsonism is rare. A series of four patients with late onset Huntington's disease presenting as levodopa responsive parkinsonism and cardiovascular dysautonomia, initially misdiagnosed as multiple system atrophy (MSA) in three patients, is reported. Levodopa treatment did not unmask significant chorea. These cases suggest the presence of a distinct phenotypic variant of Huntington's disease to be added to the differential diagnosis of other akinetic rigid syndromes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644798      PMCID: PMC1736772          DOI: 10.1136/jnnp.68.2.238

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.

Authors:  Jussi O T Sipilä; Tommi Kauko; Markku Päivärinta; Kari Majamaa
Journal:  J Neurol       Date:  2017-08-28       Impact factor: 4.849

Review 3.  Huntington's Disease-Update on Treatments.

Authors:  Kara J Wyant; Andrew J Ridder; Praveen Dayalu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 4.  Symptomatic treatment of Huntington disease.

Authors:  Octavian R Adam; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 5.  Quadruple deep brain stimulation in Huntington's disease, targeting pallidum and subthalamic nucleus: case report and review of the literature.

Authors:  D Gruber; A A Kuhn; T Schoenecker; U A Kopp; A Kivi; J Huebl; E Lobsien; B Mueller; G-H Schneider; A Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2014-04-04       Impact factor: 3.575

6.  Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease.

Authors:  A Ciammola; J Sassone; B Poletti; N Mencacci; R Benti; V Silani
Journal:  Case Rep Neurol Med       Date:  2011-09-07

7.  Nucleic Acid-Based Therapy Approaches for Huntington's Disease.

Authors:  Tatyana Vagner; Deborah Young; Alexandre Mouravlev
Journal:  Neurol Res Int       Date:  2012-01-11

Review 8.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

9.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086

Review 10.  What do we know about Late Onset Huntington's Disease?

Authors:  Sai S Chaganti; Elizabeth A McCusker; Clement T Loy
Journal:  J Huntingtons Dis       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.